Improved Glycemic Control After Long-Term Insulin Pump Use in Pediatric Patients with Type 1 Diabetes

2007 ◽  
Vol 9 (5) ◽  
pp. 421-428 ◽  
Author(s):  
Laura Scrimgeour ◽  
Erin Cobry ◽  
Kim McFann ◽  
Pat Burdick ◽  
Casey Weimer ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Pediatric Patients ◽  
Insulin Pump

Initiation of insulin pump therapy in children at diagnosis of type 1 diabetes resulted in improved long-term glycemic control

2016 ◽  
Vol 18 (1) ◽  
pp. 26-32 ◽  
Author(s):  
Eunice G. Lang ◽  
Bruce R. King ◽  
Malcolm N. Miller ◽  
Sandra V. Dunn ◽  
Darrell A. Price ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Pump Therapy

Glycemic Control in Transition‐Aged Versus Early Adults with Type 1 Diabetes and the Effect of a Government‐Funded Insulin Pump Program

2021 ◽  
Author(s):  
Shane P Mooney ◽  
Gillian L Booth ◽  
Rayzel Shulman ◽  
Yingbo Na ◽  
Alanna Weisman ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Insulin Pump

823-P: Insulin Pump Use and Glycemic Control among Patients with Type 1 Diabetes: Trends from the T1DX-QI Cohort

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 823-P
Author(s):  
NUDRAT NOOR ◽  
RYAN MCDONOUGH ◽  
EMILY CARLSON ◽  
ALLISON B. MEKHOUBAD ◽  
SUSAN HSIEH ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Insulin Pump ◽  
Diabetes Trends

scholarly journals 30-Year Cardiovascular Disease in Type 1 Diabetes: Risk and Risk Factors Differ by Long-Term Patterns of Glycemic Control

2021 ◽  
Author(s):  
Rachel G. Miller ◽  
Trevor J. Orchard ◽  
Tina Costacou
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Latent Class ◽  
Diabetes Duration ◽  
Cvd Risk ◽  
High Hba1c

<b>Objective:</b> We hypothesized that there is heterogeneity in long-term patterns of glycemic control with respect to cardiovascular disease (CVD) development in type 1 diabetes and that risk factors for CVD differ by glycemic control pattern. Thus, we estimated associations between data-derived latent HbA1c trajectories and 30-year CVD risk in the Pittsburgh Epidemiology of Diabetes Complications (EDC) study of childhood-onset (<17 years old) type 1 diabetes.<b> </b> <p><b>Research Design and Methods: </b>Participants (n=536 with ≥2 HbA1c measurements [median 6] and CVD-free at baseline; mean age 27 and diabetes duration 18 years) were followed from 1986-88 to 2016-18 to ascertain CVD incidence (CVD death, myocardial infarction, stroke, coronary revascularization or blockage ≥50%, ischemic ECG, or angina). Latent HbA1c trajectories and their association with time-to-CVD incidence were simultaneously assessed using Joint Latent Class Mixed Models.</p> <p><b>Results:</b> Two HbA1c trajectories with respect to differential CVD risk were identified: Low (HbA1c ~8% [64 mmol/mol] and improving over follow-up, 76% of cohort) and High (HbA1c ~10% [86 mmol/mol] and stable, 24%). Overall, 30-year CVD incidence was 47.4% (n=253); MACE incidence 31.0% (n=176). High HbA1c was associated with 3-fold increased CVD risk versus Low HbA1c. Both groups had similar age and diabetes duration. Non-HDLc and estimated glomerular filtration rate were associated with CVD risk only in Low HbA1c; albumin excretion rate was associated with CVD risk only in High HbA1c.<b> </b></p> <p><b>Conclusions: </b>These risk factor differences suggest that pathways to CVD may differ by glycemic control, potentially resulting in important implications for prognosis in type 1 diabetes.</p>

Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes

2017 ◽  
Vol 19 (2) ◽  
pp. 109-114 ◽  
Author(s):  
Ana María Gómez ◽  
Lisseth Fernanda Marín Carrillo ◽  
Oscar Mauricio Muñoz Velandia ◽  
Martín Alonso Rondón Sepúlveda ◽  
Carol M. Arévalo Correa ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Efficacy And Safety ◽  
Pump Therapy ◽  
Term Efficacy ◽  
Low Glucose

Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up

2021 ◽  
Vol 68 (8) ◽  
pp. 567-572
Author(s):  
Nicolás Coronel-Restrepo ◽  
Víctor Manuel Blanco ◽  
Andres Palacio ◽  
Alex Ramírez-Rincón ◽  
Sebastián Arbeláez ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Real World ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Pump Therapy ◽  
Long Term Follow Up

scholarly journals Efficacy and safety of long-term insulin pump treatment in patients with type 1 diabetes aged over 50 years

2020 ◽  
Vol 67 (3) ◽  
pp. 367-371
Author(s):  
Bartłomiej Matejko ◽  
Sabina Krzyżowska ◽  
Beata Kieć-Wilk ◽  
Maciej Tadeusz Malecki ◽  
Tomasz Klupa
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Pump ◽  
Efficacy And Safety

scholarly journals Response to Comment on Lacy et al. Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care 2018;41:2339–2345

Diabetes Care ◽  
2019 ◽  
Vol 42 (4) ◽  
pp. e69-e69
Author(s):  
Mary E. Lacy ◽  
Paola Gilsanz ◽  
Andrew J. Karter ◽  
Charles P. Quesenberry ◽  
Mark J. Pletcher ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Diabetes Care ◽  
Dementia Risk
Sign in / Sign up

Export Citation Format

Share Document